These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 29974177)
1. Imaging and staging of neuroendocrine cervical cancer. Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177 [TBL] [Abstract][Full Text] [Related]
2. MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations. Duan X; Ban X; Zhang X; Hu H; Li G; Wang D; Wang CQ; Zhang F; Shen J Eur Radiol; 2016 Dec; 26(12):4293-4302. PubMed ID: 26995208 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073 [TBL] [Abstract][Full Text] [Related]
4. Comparative genomics of high grade neuroendocrine carcinoma of the cervix. Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India. Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245 [TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and survival in neuroendocrine cervical cancer. Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621 [TBL] [Abstract][Full Text] [Related]
7. Natural history and outcome of neuroendocrine carcinoma of the cervix. Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865 [TBL] [Abstract][Full Text] [Related]
8. Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix. Goto S; Terao Y; Kamigaki T; Takimoto R; Naitoh K; Makita K; Yasumoto K; Okada S; Takizawa K; Yokomichi N; Suzuki N; Takeda S Anticancer Res; 2020 Aug; 40(8):4741-4748. PubMed ID: 32727800 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix. Zhu R; Wu H; Chen B; Pang J; Huo Z Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945 [TBL] [Abstract][Full Text] [Related]
11. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Kim C; Salvo G; Ishikawa M; Chen TC; Jhingran A; Bhosale P; Ramalingam P; Frumovitz M Gynecol Oncol; 2023 Mar; 170():328-332. PubMed ID: 36773379 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications. Wang KL; Yang YC; Wang TY; Chen JR; Chen TC; Chen HS; Su TH; Wang KG J Chemother; 2006 Apr; 18(2):209-16. PubMed ID: 16736891 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study. Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983 [TBL] [Abstract][Full Text] [Related]
14. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix. Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425 [TBL] [Abstract][Full Text] [Related]
15. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Salvo G; Gonzalez Martin A; Gonzales NR; Frumovitz M Int J Gynecol Cancer; 2019 Jul; 29(6):986-995. PubMed ID: 31263021 [TBL] [Abstract][Full Text] [Related]
16. PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line. Lai ZY; Yeo HY; Chen YT; Chang KM; Chen TC; Chuang YJ; Chang SJ Oncotarget; 2017 Jul; 8(28):45323-45334. PubMed ID: 28484083 [TBL] [Abstract][Full Text] [Related]
18. Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER-based study. Yu H; Lin Y; Lin J; Xie N; Liu L; Deng S; Sun Y Cancer Med; 2024 Aug; 13(15):e70066. PubMed ID: 39118477 [TBL] [Abstract][Full Text] [Related]
19. Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer. Zeng F; Tuo Y; Liu D; He M J Obstet Gynaecol Res; 2020 Jun; 46(6):950-954. PubMed ID: 32266759 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment for neuroendocrine carcinoma of the uterine cervix. Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]